This new approach and experience used within multiple industries will benefit daily work as a sponsor, biotech company, CRO, and research site and bring researchers closer to decentralized trials.

TORONTO (PRWEB)
November 28, 2022

Ever thought about how cloud technology could solve the challenges in conducting clinical trials and bring them closer to patients?

In this webinar, the featured speakers will present a cloud technology approach and their experiences in bringing even more technology into the industry. Cloud solutions of different service providers and Clinscience’s Genius Suite Applications can improve patient recruitment, and minimize patient drop-out rate resulting in quicker turnarounds, better quality data, and at the end of the day, improve cost efficiencies for clinical studies.

The speakers will discuss the benefits of: Cloud technology vs. on-site infrastructure; Event-driven architecture and applications for data-driven decisions; How cloud providers like Amazon AWS and Microsoft Azure in clinical trials enable out-of-the-box solutions; And Voice eConsent — how this service within cloud infrastructure can improve patient recruitment.

This new approach and experience used within multiple industries will benefit daily work as a sponsor, biotech company, CRO, and research site and bring researchers closer to decentralized trials. In addition, data streams and IoT will be cleaner, more efficient, and less prone to human error, as everything is interconnected for multiple stakeholders within the clinical trial process.

Adopting cloud technology solutions benefits the patient — less paperwork, fewer site visits, and less hassle in participating in a clinical trial. With more transparency, cleaner data and greater access to information needed for multiple stakeholders in the clinical trial process, they save time and improve the performance of a clinical study.

Register for this webinar, during which two specialists will discuss their perspective on bringing cloud technology and other expanded solutions in clinical trials to life.

Join experts from Clinscience, Peter Rottmann, Chief Technology Officer; and Damian Bauer, Associate Director of Clinical Data Integration, Clinscience, for the live webinar on Monday, December 12, 2022, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit A Review of Cloud Technology & Solutions that Solve Clinical Trial Challenges.

ABOUT CLINSCIENCE

Clinscience is a global SMART CRO with hubs across five countries in Europe and the United States; as well as offers a satellite presence in five European countries. Since 2020, Clinscience offers full (end-to-end) CRO services from Protocol Development to Final Study Report. Over 150 Biotech Clients trust Our Brand and we expect many more in the near future. Our uncomplicated procedures and Data-driven approach harnessed with state-of-the-art technology allow us to be smart and agile in meeting our Clients’ needs. Clinscience is a global CRO company offering smart CRO Services, from protocol creation to final study report development. The Company has offices in Poland, Spain, Italy, Germany, US, and India and has a satellite presence in additional 6 European countries. More than 150 Biotechnology companies across Europe and the US trust the Clinscience brand. Clinscience specializes in Oncology, Hemato-Oncology, Cardiovascular Diseases, and Neurology. It has managed more than 500 studies and recruited over 157,352 patients across 3,974 sites globally. The Company’s procedures and Data-driven approach, harnessed with the Genius Suite™ technology, work together to give the Clients power and flexibility to address even the most unique needs. Clinscience is part of a publicly-traded parent company, Neuca Plc, an organization in the pharmaceutical wholesaling and healthcare industry that provides the structure to meet the needs of commercial and non-commercial studies. Visit http://www.clinscience.com for more information.

Clinscience Press Contact:

Agnieszka Piotrowska

Email: a.piotrowska@lensomai.com

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

The featured speaker presents a case study of how a change in the mindset of data vendors can drive more collaborative and impactful translational and clinical research and support both HCP and patient communities in finding more targeted care pathways.

TORONTO (PRWEB)
November 28, 2022

For many years, data vendors have focused exclusively on the enablement of pharma and CROs to drive more impactful, efficient clinical research. However, the need to enable healthcare professionals (HCPs) with data to direct better patient care through clinical trial awareness and accessibility hasn’t been considered.

In this webinar, the featured speaker presents a case study of how a change in the mindset of data vendors can drive more collaborative and impactful translational and clinical research and support both HCP and patient communities in finding more targeted care pathways.

Register for this webinar to learn how HCPs can leverage data insights and analytics to optimize patient care and clinical research.

Join Barbara Argibay Gonzalez, Vice President Data Division Management, Anju Software, for the live webinar on Thursday, December 8, 2022 at 11am EST (5pm CET/EU-Central).

For more information, or to register for this event, visit Optimizing Patient Care & Clinical Research: How HCPs can Leverage Data Insights & Analytics.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

We’ll walk through thermal ramp and isothermal experiments, repeat freeze-thaws and ultimately show you some crucial pieces of the AAV stability puzzle.

TORONTO (PRWEB)
November 28, 2022

Problem: You worked hard on zeroing in on a serotype, then establishing a cell line and finally purifying only full, monodisperse AAV. Now you want to make sure that your AAV is in a formulation that keeps the capsids stable, prevents them from aggregating and has them retain their payload until you can put them to use.

Solution: Uncle is the all-in-one stability platform to help you track stability of your AAV under different conditions. Run a quick thermal ramp, test long-term stability and check out how the vector performs in freeze-thaw cycles. Uncle has all these applications covered and requires only 9 µL per sample for up to 48 samples.

Proof: Tune in to our webinar and see for yourself how Uncle is used to characterize stability of 3 serotypes in 3 formulation conditions. We’ll walk through thermal ramp and isothermal experiments, repeat freeze-thaws and ultimately show you some crucial pieces of the AAV stability puzzle.

Join Andre Mueller, PhD, Product Manager Uncle, Unchained Labs, for the live webinar on Thursday, December 8, 2022, at 12pm EST (5pm GMT/UK).

For more information, or to register for this event, visit Dive Deep Into AAV Capsid Stability & Genome Ejection With Uncle.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Bioidentical hormones are lab-made, but they are identical to the ones your body makes naturally. They’re easily absorbed, and compounded dosing ensures that treatment is appropriate for each patient. It’s personalized medicine for menopause treatment.

CLEARWATER, Fla. (PRWEB)
November 28, 2022

For two decades, women and their doctors have shied away from hormone replacement to erase menopause symptoms. Now-outdated research warned of increased cancer risk from hormone replacement therapy. As a result, a generation of women struggled through menopause without effective treatment to manage their physical and emotional symptoms. Today, new scientific data and bioidentical hormone treatment are changing the landscape for menopause treatment. “We know things now about hormone replacement that we didn’t fully understand 20 years ago,” says Cynthia Elliott, M.D., owner and primary practitioner of Skinspirations, a cosmetic and regenerative medical practice. She adds, “New information and new hormone treatments mean the benefits of hormone replacement outweigh the risks.”

For decades, scientists and doctors have known that hormone replacement therapy can reduce or eliminate menopause symptoms. However, the practice went out of favor after a 2002 study showed that women who took a combination of estrogen and progestin had an increased risk of breast cancer, heart attacks, stroke, and blood clots.(1) In the 20 years since, researchers learned more about the relationship between hormone replacement therapy and overall health. New data shows fewer risks than initially feared and many more benefits to women’s health and quality of life during menopause.

In light of the new data, doctors are now again prescribing FDA-approved hormone replacement for women during menopause. Women benefit from new formulations of naturally derived bioidentical hormones. In addition, doctors see benefits from prescribing compounded hormone therapies with dosages customized for each patient.(2)

“Some regulators have questions about the safety and efficacy of compounded hormone treatments,” Dr. Elliott notes, “but doctors and patients already know how well they work. Bioidentical hormones are lab-made, but they are identical to the ones your body makes naturally. They’re easily absorbed, and compounded dosing ensures that treatment is appropriate for each patient. It’s personalized medicine for menopause treatment.”

Physicians like Dr. Elliott believe that bioidentical hormone therapies and custom dosing represent a breakthrough in the treatment of menopause. When overseen by an experienced doctor, these new hormone treatments can be an important part of a holistic approach to managing health through menopause. “My patients come to me for support during a new phase of life.” Dr. Elliott explains, “They want to look better, and they want to feel better. Hormone replacement is one effective way of achieving their wellness goals.”

Dr. Elliott’s practice is adding hormone replacement therapy to its list of comprehensive antiaging services in late 2022. In addition to treatment for menopause symptoms, patients can receive aesthetic services, body contouring treatments, and regenerative treatments for musculoskeletal conditions.

About Dr. Cynthia Elliott and Skinspirations

Cynthia Elliott, M.D., is the owner and primary practitioner of Skinspirations, a cosmetic and regenerative medical practice that provides injectable and laser aesthetic treatments, professional skincare, body contouring, and regenerative treatments for aesthetic and musculoskeletal concerns. Located in Clearwater, Florida, Dr. Elliott is valued for her medical expertise and her training on the national level for the makers of Botox® Cosmetic and Juvéderm and internationally for Cutera Lasers. Her patients seek her expertise, knowing that she and her long-tenured staff have trained many professionals in the Tampa Bay area. Skinspirations has performed over 88,000 cosmetic medical treatments since 2005 and is known for the most effective aesthetic and regenerative medical treatments available, providing the quality results that other practitioners are still trying to learn. Dr. Elliott, whose medical training began in emergency medicine, currently serves as an expert witness in Cosmetic Medicine for the Florida Board of Medicine. For more information, visit http://www.skinspirations.com.

Sources:

1) Elsesser, Kim, Here’s The Current Thinking On Hormone Therapy (It’s Not What You Heard 20 Years Ago), April 19, 2022, Forbes, forbes.com/sites/kimelsesser/2022/04/19/heres-the-current-thinking-on-hormone-therapy-its-not-what-you-heard-20-years-ago/?sh=310ff66d4787

2) Stakeholders Urge FDA to Protect Access to Compounded Hormone Therapies, September 13, 2022, Pharmacy Times, pharmacytimes.com/view/stakeholders-urge-fda-to-protect-access-to-compounded-hormone-therapies

Share article on social media or email:

“Through our partnership with Meridian, Hampton Family Practice will help shape the future of medicine and healthcare. Conducting these research studies enables us to expand the care options we provide for families and gives our community a way to potentially improve lives worldwide.”

HAMPTON, Va. (PRWEB)
November 28, 2022

Meridian Clinical Research, a leading multi-specialty site network, has opened a new site in Hampton, VA. Meridian is partnering with Hampton Family Practice, a premier provider of compassionate family care that has served the area for 45 years. The research site will be located within the Hampton Family Practice clinic at 9 Manhattan Square, Suite A, Hampton, VA 23666.

The following Hampton Family Practice physicians will serve as principal investigators for Meridian:

As principal investigators, the physicians will oversee clinical trials related to general medicine, including vaccine studies for people of all ages.

Nicole Osborn, Founder and CEO of Meridian, said the company is looking forward to making clinical trials more accessible to more Virginians. “Many of the patients we serve regularly travel from the Hampton area to our Norfolk and Portsmouth sites to participate in clinical trials,” said Osborn. “This will bring more research opportunities to Hampton, empowering more people to participate and ultimately support the development of new medications.”

“Through our partnership with Meridian, Hampton Family Practice will help shape the future of medicine and healthcare,” said Brian McCormick, MD. “Conducting these research studies enables us to expand the care options we provide for families and gives our community a way to potentially improve lives worldwide.”

Clinical trials (also called “clinical studies” or “research studies”) help determine if investigational medicines, medical devices, and tests are safe and effective. These studies offer a way for almost anyone — regardless of age, ethnicity, or background — to help move science forward. Eligible participants usually receive compensation for study-related time and travel.

Meridian now has 38 sites nationwide. The site will be Meridian’s third in Virginia and follows the company’s opening of a family medicine research clinic in Portsmouth last year. Meridian was founded in 1999 and has enrolled more than 85,000 participants into clinical trials since its inception.

If you’re interested in joining a clinical trial at Meridian, visit mcrmed.com/find-study. For more information about careers at Meridian and current openings in Hampton, visit mcrmed.com/careers.

***

ABOUT MERIDIAN CLINICAL RESEARCH

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase 1-4 clinical trials at investigative sites nationwide. Meridian supports research across numerous therapeutic areas and excels in high-volume vaccine trials. For more information, visit mcrmed.com.

MEDIA INQUIRIES

Robert Jones

Meridian Clinical Research

rjones@mcrmed.com

Share article on social media or email:

MELVILLE, N.Y. (PRWEB)
November 28, 2022

Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New Jersey, Connecticut, Massachusetts, and New Hampshire, announces today the opening of a new clinic in Totowa, New Jersey. The addition of this clinic elevates Professional’s footprint in New Jersey to 65 locations, totaling over 190 locations across the Northeast.

The Totowa clinic is located at 205 Route 46. Even more patients in New Jersey will have greater access to the clinical expertise and cutting-edge therapeutics offered by Professional.

Dr. Nicholas Licameli, PT, DPT and Clinical Director Partner, remarks, “I am honored to serve the Totowa community and immerse myself into its culture. I have a passion for learning, dedication to family and above all a commitment to my community to improve quality of life and inspire healthy living.”

Dr. Licameli completed his doctorate in Physical Therapy at Rutgers School of Biomedical and Health Services. He is an internationally recognized authority on blood flow restriction training, writes for health and fitness publications, is a regular guest on health and fitness podcasts and is an expert on telehealth. He is an author and passionate educator. He also treats patients of all ages including high school, collegiate, and professional athletes, prenatal and postpartum patients and so much more with an overall emphasis on the bio-psycho-social holistic approach to patient care.

Professional’s latest opening reflects their ongoing commitment to providing world-class patient care with convenience remaining a top priority. This clinic was opened under Professional PT’s partnership program that provides a unique affiliation solution to clinicians and leaders who are vested in ownership and operations.

Services available at Professional Physical Therapy in Totowa include:

• Physical Therapy – Our physical therapists treat medical conditions that limit functional mobility and help develop a customized treatment plan to improve the ability to move, reduce pain, restore function, and prevent disability.
• Free Injury Screens – If you have an ache, pain, performance issue, or question, you can schedule a 1-on-1 session with one of our physical therapists. We evaluate your condition to help recommend which treatments may be effective, including making a referral if a specialist is advised.
• Blood Flow Restriction Therapy – This type of therapy enables patients to make greater strength gains while lifting lighter loads, thereby reducing the overall stress placed on the limb. BFR is often used to treat patients following upper and lower extremity services including ACL reconstruction, hip/knee replacement, rotator cuff and tendon repair.
• TMJ Therapy – If you are experiencing jaw pain our physical therapists can provide a treatment plan to strengthen and stretch the muscles in your face to reduce pain and discomfort.
• Vestibular Therapy – We have specialists that can design an exercise-based treatment plan to help reduce feeling of vertigo or dizziness and improve balance and coordination.

Additionally, the Totowa clinic:

• Accepts most major insurance plans, so you don’t need to worry about your visits being covered.
• Offers convenient hours, including late evenings.
• Does not require a physician referral or prescription to start treatment.
• Schedules each initial evaluation quickly, sometime the same or next day.
• Provides ongoing patient education on diagnosis, treatment plans and prescribed home-exercise programs.

Professional Physical Therapy currently operates widely across five of the Northeast states. For more information and a list of all Professional Physical Therapy locations and services, please visit http://www.professionalpt.com

About Professional Physical Therapy

Professional Physical Therapy was founded in 1999 and is an industry leader, providing private outpatient physical and hand therapy services throughout the Northeast. Our clinical team is comprised of multi-specialty Physical, Hand and Occupational Therapists who can treat a wide variety of orthopedic injuries and conditions with excellence. Today, Professional has grown to include over 190 facilities in New York, New Jersey, Connecticut, Massachusetts, and New Hampshire.

Share article on social media or email:

Sunbit is the modern patient financing tool of choice for dentists

We recommend Sunbit’s patient financing solution. The “why” is pretty simple. The results have been incredible—$2.1 million in incremental production, thousands of additional patients treated, and a more confident office team that knows they can trust the technology to help patients in need.

LOS ANGELES (PRWEB)
November 28, 2022

Sunbit, the company building financial technology for everyday expenses, today announced that its leading patient financing technology is being embraced by dentists and patients across the country. Industry partners, DSOs, and independent practices have all chosen Sunbit because it offers access to fair, fast, and transparent financing terms, without hidden fees or “gotchas.” As of November 2022, dental is the fastest-growing market for the company, which has already served more than 1.4 million customers across verticals.

“Virtually everyone in the country can benefit from top-notch dental coverage. However, millions of Americans are forced to choose between paying out-of-pocket for necessary, and often unexpected, dental expenses or declining essential care recommended by their provider,” said Jay Letwat, Vice President of Dental, Sunbit. “Even patients with private dental insurance face coverage caps, which all but guarantee that any significant treatment will require a hefty out-of-pocket cost as well.”

Dentists are acutely aware of the need for fair and accessible patient financing. But, finding the right solution is difficult. According to a recent survey of 920 dentists, 83% of dental professionals offer a patient financing option, yet only 8% are completely satisfied with their solution.¹ This significant gap can only be addressed by a solution that approves the vast majority of applicants, within moments at checkout, and with fair terms, that enable patients to hold onto more of their hard-earned dollars.

According to the same survey, treatment acceptance increases by 57% once a patient qualifies for a third-party financing solution.

“We’ve utilized Sunbit to replace other financing tools, including in-house financing, and it’s been a game-changer for our 50 locations. The simple and fast application process creates a much better experience for both patients and staff. We’ve provided a significantly greater amount of dentistry than we could have had we not had Sunbit as a tool. In fact, since launching, 90% of our patients who have applied have been approved, which has allowed thousands of patients to receive the dental care they needed, many of whom likely would not have been able to otherwise,” said Lorri Detrick, Chief Operations Officer, Riccobene Associates.

Sunbit technology can be found in more than 6,000 dental locations, and in more than 550 DSOs, with more than 500 new offices being added each month. In addition, Sunbit’s technology is integrated with multiple platforms serving small- and medium-sized dental practices.

As Sunbit continues to cement partnerships with leading organizations such as Straumann Group, Kleer, Dental Whale and many industry-leading providers of lab services, software, consumables, and consulting services, its footprint is expanding exponentially.

Sunbit technology offers access to financing for dental procedures with 6 to 72-month payment plan options, and 85% of patients who apply using Sunbit technology are approved. All well-qualified patients get access to true no-interest payment plans at participating practices. By powering the application process and managing the collections process, Sunbit takes the burden of management out of the hands of the practices.

“Sunbit is a one-stop shop for patients across the credit spectrum. When Independence DSO partners with dental offices, one of the first things we recommend is Sunbit’s patient financing solution. The “why” is pretty simple. It helps our partner practices serve more patients and generates incremental production for the offices,” said John Geary, Chief Operating Officer, Independence Dental Services. He added, “I have nearly 20 years of experience in retail healthcare & dental, and Sunbit is the most technologically advanced solution, helping so many people, and it is super simple for offices and patients to use. The results have been incredible—$2.1 million in incremental production, thousands of additional patients treated, and a more confident office team that knows they can trust the technology to help people in need.”

About Sunbit

Sunbit builds financial technology for real life. Our technology eases the stress of paying for life’s expenses by giving people more options on how and when they pay. Sunbit offers a next-generation, no-fee credit card that can be managed through a powerful mobile app, as well as a point-of-sale payment option available at more than 16,000 service locations, including auto dealership service centers, optical practices, dentist offices, veterinary clinics, and specialty healthcare services. Sunbit was included on the 2022 Inc. 5000 list. The financial technology company has also been named as a Most Loved Workplace®, Best Point of Sale Company, A N.A. Deloitte Technology Fast 500 company and as a Top Fintech Startup by CB Insights.

Loans are made by Transportation Alliance Bank, Inc., dba TAB Bank, which determines qualifications for and terms of credit. The Sunbit Card is issued by TAB Bank, pursuant to a license from Visa U.S.A. Inc. Use of the card is subject to the cardholder agreement.

1-Sunbit Dental Professionals Survey: n=920 dental professionals age 18 or older nationwide. Aug 3 – Sept 12, 2022

Follow Sunbit:

Twitter

LinkedIn

Facebook

Instagram

Media Contact:

media@sunbit.com

Share article on social media or email:

“Since opening our doors, our mission has been to help our clients reduce cost and prevent readmissions. We are delighted that this partnership will allow us to continue this mission and reach more people than before.” – Greg Cooper, Managing Partner of IncreMedical

PHOENIX, Ariz. (PRWEB)
November 28, 2022

IncreMedical Therapy Solutions (IncreMedical), a member of the Confluent Health family, is proud to announce their expanded footprint will span 21 additional managed locations across 8 states with the recent acquisition of the Managed Services Agreement (MSA) division of Exos, a corporate wellness provider and physical therapy company.

“We couldn’t be more excited to join the IncreMedical family,” said Exos’ VP and General Manager, Brett Rivers, PT. “We have an incredibly talented team and amazing medical partners. We have worked hard to build the MSA business at Exos and have been in search of a reputable business partner that can help us continue along our growth trajectory. IncreMedical is an established leader with a reputation for superior customer service and quality care. We can’t wait to see what this partnership will bring!”

While patients will continue to see the same compassionate care and services from Exos, the clinical team will have greater access to the nationally recognized physical therapy education company Evidence In Motion, the leading provider of employee safety, Fit for Work, and other valuable business resources.

“We are thrilled to welcome the Exos MSA business to the IncreMedical family,” said Greg Cooper, Managing Partner of IncreMedical. “Since opening our doors, our mission has been to help our clients reduce cost and prevent readmissions with an emphasis on population health and improved outcomes for patients. We are delighted that this partnership will allow us to continue this mission and reach more people than before.”

“We are proud to partner with IncreMedical and are excited to welcome the MSA business of Exos to the Confluent family” says Confluent Health’s President and CEO Larry Benz, PT, DPT, OCS, MBA, FAPTA. “Greg’s entire team are pre-eminent clinical leaders and bringing in Exos is going to add significant value as we grow together. Our partnership has endless possibilities.”

This partnership will further expand IncreMedical’s existing footprint of 41 locations across Indiana, Georgia, and Wyoming to Arkansas, California, Colorado, Florida, Louisiana, Montana, Oklahoma and Tennessee.

For more information about IncreMedical please visit Confluent Health’s official release. For more information about Exos, or to meet with one of their expert therapists, please visit https://www.physicaltherapy.teamexos.com/ for location information and phone numbers.

###

About Incremedical Therapy Solutions:

Incremedical provides post-acute management services for Accountable Care Organizations, Hospitals, and Physician Practices to include physical therapy, risk stratification, and patient engagement strategies with a focus on preventable hospital re-admissions. Incremedical Therapy Solutions serves clients and patients in Georgia, Indiana, and Wyoming.

About Confluent Health:

Confluent Health is a Louisville, Kentucky-based private holding company focused on creating a healthcare system that recognizes physical and occupational therapy providers as the Best First Choice for preventing and managing musculoskeletal and movement disorders. Confluent Health offers the following management services: evidence-based practice, patient loyalty, regulatory assurance, marketing and branding, clinic operations, hiring and retention, strategy, accounting and finance, and customer service to Incremedical Therapy Solutions, Advanced and Preferred Physical Therapy, Baton Rouge Physical Therapy-Lake, BreakThrough Physical Therapy, Capitol Physical Therapy, Colorado in Motion, Confluent Physical Therapy, El Paso Physical Therapy Specialists, the Evidence In Motion family of companies, Fit For Work, HPRC, Lake Center for Rehab, Mountain River Physical Therapy, OSPT, Pappas | OPT Physical Therapy, Physical Therapy Central, ProActive Physical Therapy Specialists, ProRehab Physical Therapy, PTPN, Redbud Physical Therapy, Rehab Therapy Works, RET Physical Therapy Group, SporTherapy, TOSPT, Texas Physical Therapy Specialists, Western Berks Physical Therapy and Wellness Group and Xcel Sports Medicine. Together, these companies share a common ownership team and are committed to developing a learning, purpose, and coaching culture.

Share article on social media or email: